People with multiple sclerosis (MS) are about twice as likely to develop restless legs syndrome (RLS) — a constant urge to move the legs during rest or inactivity — than those without the disease, according to a study in Spain. Among MS patients, having a family history of…
Subtle drops in activity levels detected by wrist-worn sensors — especially in the morning — may predict worsening disability and brain tissue loss in people with multiple sclerosis (MS), according to a study. The data suggest that continuous monitoring with these devices could reveal early signs of disease progression…
A researcher at the Walter and Eliza Hall Institute in Australia has received funding from MS Australia to uncover how genetic risk factors contribute to multiple sclerosis (MS). Hamish King, PhD, will use the AU$400,000 (about $281,000) grant to investigate how more than 100 genetic changes linked to MS…
A “molecular atlas” of disease that can predict illness years before symptoms appear is the goal of a massive new research project analyzing blood samples from U.S. military service members. Known as ORIGIN, the initiative uses stored samples from the Department of Defense to hunt for early warning signs of…
A Phase 1 clinical trial testing azercabtagene zapreleucel (azer-cel), TG Therapeutics’ CAR-T-cell therapy, in progressive forms of multiple sclerosis (MS) is now recruiting participants at eight sites across the U.S. The study (NCT06680037) is expected to enroll up to 32 adults with primary progressive MS…
Get regular updates to your inbox.
